未登录Elimination of arctic variant rabies in red foxes, metropolitan Toronto
Rosatte, R. C.; Power, M. J.; Donovan, D.; Davies, J. C.; Allan, M.; Bachmann, P.; Stevenson, B.; Wandeler, A.; Muldoon, F. .png)
分享.png)
收藏分享 收藏 Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development GroupGiaccone, G; Smit, EF; de Jonge, M; Dansin, E; Briasoulis, E; Ardizzoni, A; Douillard, JY; Spaeth, D; Lacombe, D; Baron, B; Bachmann, P; Fumoleau, P 分享 收藏 Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer.: A phase II trial of the EORTC-new drug development groupBriasoulis, E; Pavlidis, N; Terret, C; Bauer, J; Fiedler, W; Schöffski, P; Raoul, JL; Hess, D; Selvais, R; Lacombe, D; Bachmann, P; Fumoleau, P 分享 收藏 分享 收藏 Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasisJha, TK; Sundar, S; Thakur, CP; Bachmann, P; Karbwang, J; Fischer, C; Voss, A; Berman, J 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
